Cost effectiveness of lowering cholesterol. Full treatment of the costs and benefits is needed
BMJ
.
1996 Nov 2;313(7065):1143; author reply 1144.
doi: 10.1136/bmj.313.7065.1143.
Authors
A S Wierzbicki
,
T M Reynolds
PMID:
8916709
PMCID:
PMC2352460
DOI:
10.1136/bmj.313.7065.1143
No abstract available
Publication types
Comment
Letter
MeSH terms
Cardiovascular Diseases / prevention & control
Cost-Benefit Analysis
Humans
Hypercholesterolemia / prevention & control*
Life Tables
Risk Factors